Life Sciences Report

RXi-MirImmune Merger Aims to Unlock Value Through Groundbreaking Technology

February 23, 2017 The Life Sciences Report RXi Pharmaceuticals’ proprietary self-delivering RNAi (sd-rxRNA) platform offers efficient delivery to cells ex vivo, an application with tremendous potential in immuno-oncology. It’s no surprise then that RXi has acquired MirImmune, a company that has been focusing on the next generation of immunotherapies for the treatment of cancer. In …

RXi-MirImmune Merger Aims to Unlock Value Through Groundbreaking Technology Read More »

Investing in Life Sciences Under the Trump Presidency

Source: Kristin McFarland for The Life Sciences Report  (2/16/17) Stocks in all areas of life sciences including biotech to pharma have been on a roller coaster since Donald Trump won the election in November. Wealth advisor Kristin McFarland discusses the big picture for pharmaceutical investment under the new administration. As of February, a great deal of …

Investing in Life Sciences Under the Trump Presidency Read More »

19 Companies Selected for the 2017 Small-Cap Biotech Watchlist

Source: The Life Sciences Report  (1/3/17) Editors Note: Dudley Baker here with http://CommonStockWarrants.com Several of the companies mentioned below have stock warrants trading which are in our databases with complete details. If you like the company, you must love the stock warrants trading on those companies. ________________________________________________________________________________ Now in its fifth year, the 2017 Life Sciences …

19 Companies Selected for the 2017 Small-Cap Biotech Watchlist Read More »

Scroll to Top